{
    "id": "0788",
    "question": "A 26-year-old gravida 2 para 1 at 24 weeks gestation is admitted to the labor and delivery suite with mild abdominal cramps, uterine contractions, and a watery vaginal discharge. She has a history of preterm birth. The vital signs are as follows: blood pressure 125/80 mm Hg; heart rate 100/min; respiratory rate 13/min; and temperature 36.6\u2103 (97.9\u2109). The pelvic examination reveals cervical softening and shortening. Transvaginal ultrasound shows a cervical length of 12 mm, which is consistent with preterm labor. A tocolytic and a single dose of betamethasone are administered. Betamethasone stimulates which fetal cells?",
    "options": {
        "A": "Goblet cells",
        "B": "Bronchial epithelial cells",
        "C": "Type II pneumocytes",
        "D": "Vascular smooth myocytes"
    },
    "answer": "C",
    "predict": "To answer this question, let's break down the information provided and analyze it step by step: 1. **Clinical Presentation**: The patient is a 26-year-old woman at 24 weeks gestation with mild abdominal cramps, uterine contractions, and a watery vaginal discharge. These symptoms are consistent with preterm labor. 2. **History**: The patient has a history of preterm birth, which is a significant risk factor for preterm labor. 3. **Vital Signs**: The patient's vital signs are within normal limits, which suggests that there are no acute distressing conditions at this time. 4. **Pelvic Examination**: The examination reveals cervical softening and shortening, which is consistent with preterm labor. 5. **Ultrasound Findings**: The transvaginal ultrasound confirms a cervical length of 12 mm, which is consistent with preterm labor. 6. **Treatment**: A tocolytic (a medication to stop or slow preterm labor) and a single dose of betamethasone are administered. 7. **Betamethasone's Effect on Fetal Cells**: Betamethasone is a corticosteroid medication used to accelerate fetal lung maturation in anticipation of preterm birth. It stimulates the production of surfactant in the fetal lungs, which reduces the risk of respiratory distress syndrome (RDS) in the newborn. Now, considering the options provided: - **A. Goblet cells**: These cells are found in the epithelial lining of the respiratory, urinary, and gastrointestinal tracts and produce mucus. Betamethasone does not primarily stimulate these cells. - **B. Bronchial epithelial cells**: These cells line the airways and produce mucus. While betamethasone may have some effects on the respiratory system, it does not primarily stimulate these cells. - **C. Type II pneumocytes**: These cells produce surfactant, a substance that reduces the surface tension in the lungs, allowing for easier expansion during breathing. Betamethasone stimulates the production of surfactant in these cells, making this the correct answer. - **D. Vascular smooth myocytes**: These cells are involved in the smooth muscle layer of blood vessels. Betamethasone does not primarily stimulate these cells. Therefore, the correct answer is: ```json {\"step_by_step_thinking\": \"Betamethasone stimulates Type II pneumocytes to produce surfactant, reducing the risk of respiratory distress syndrome in a preterm infant.\", \"answer_choice\": \"C\"} ```",
    "snippets": [],
    "scores": [],
    "execution_time": 49.96964144706726
}